Literature DB >> 12740864

Neurotoxic methamphetamine regimen severely impairs recognition memory in rats.

Nadja Schröder1, Steven J O'Dell, John F Marshall.   

Abstract

Methamphetamine (mAMPH), when administered repeatedly to rodents or primates, is neurotoxic to some cortical neurons and to forebrain dopaminergic and serotonergic axon terminals. The aim of the present study was to investigate the effects of a neurotoxic regimen of mAMPH on two hippocampus-dependent memory tasks: object recognition, a nonspatial memory task, and the Morris water maze, a spatial memory task. Male rats were treated with mAMPH (4 x 4.0 mg/kg, s.c.) or saline and trained in the object recognition task 1 week and 3 weeks later. During training, animals explored two identical copies of the same object. In retention test sessions one of the objects was replaced by a novel object. mAMPH-treated rats showed no recognition memory during the short-term memory (STM) test, given 90 min after the training session, and showed marked impairments in the long-term memory (LTM) test, given 24 h after training. Even 3 weeks after drug injections, the mAMPH-treated animals were unable to discriminate between the novel and familiar objects during both STM and LTM tests. Despite the severe deficits observed in the recognition memory, no effects of prior mAMPH treatment were seen in the water maze task. Damage to monoamine terminals was confirmed by significant 30-40% losses of [(125)I]RTI-55 binding to striatal dopamine transporter and hippocampal serotonin transporter sites at both 1 and 3 weeks after mAMPH treatments. Thus, administration of mAMPH restricted to a single day can produce a profound, persistent, and selective deficit in a nonspatial hippocampus-dependent memory. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12740864     DOI: 10.1002/syn.10210

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  62 in total

1.  Altered learning and Arc-regulated consolidation of learning in striatum by methamphetamine-induced neurotoxicity.

Authors:  Elissa D Pastuzyn; David E Chapman; Karen S Wilcox; Kristen A Keefe
Journal:  Neuropsychopharmacology       Date:  2011-11-09       Impact factor: 7.853

2.  Prior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrations.

Authors:  Lisa M McFadden; Madison M Hunt; Paula L Vieira-Brock; Janice Muehle; Shannon M Nielsen; Scott C Allen; Glen R Hanson; Annette E Fleckenstein
Journal:  Drug Alcohol Depend       Date:  2012-05-28       Impact factor: 4.492

Review 3.  Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models.

Authors:  L Lyon; L M Saksida; T J Bussey
Journal:  Psychopharmacology (Berl)       Date:  2011-11-10       Impact factor: 4.530

Review 4.  The need for speed: an update on methamphetamine addiction.

Authors:  Alasdair M Barr; William J Panenka; G William MacEwan; Allen E Thornton; Donna J Lang; William G Honer; Tania Lecomte
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

Review 5.  Modulators in concert for cognition: modulator interactions in the prefrontal cortex.

Authors:  Lisa A Briand; Howard Gritton; William M Howe; Damon A Young; Martin Sarter
Journal:  Prog Neurobiol       Date:  2007-06-30       Impact factor: 11.685

Review 6.  Neuroprotective effect of atypical antipsychotics in cognitive and non-cognitive behavioral impairment in animal models.

Authors:  Jue He; Jiming Kong; Qing-Rong Tan; Xin-Min Li
Journal:  Cell Adh Migr       Date:  2009-01-13       Impact factor: 3.405

7.  Subchronic oral administration of Benzo[a]pyrene impairs motor and cognitive behavior and modulates S100B levels and MAPKs in rats.

Authors:  Erica Santos Maciel; Regina Biasibetti; Ana Paula Costa; Paula Lunardi; Rebeca Vargas Antunes Schunck; Gabriela Curbeti Becker; Marcelo Dutra Arbo; Eliane Dallegrave; Carlos Alberto Gonçalves; Paulo H Nascimento Saldiva; Solange Cristina Garcia; Rodrigo Bainy Leal; Mirna Bainy Leal
Journal:  Neurochem Res       Date:  2014-03-02       Impact factor: 3.996

Review 8.  Nucleus accumbens invulnerability to methamphetamine neurotoxicity.

Authors:  Donald M Kuhn; Mariana Angoa-Pérez; David M Thomas
Journal:  ILAR J       Date:  2011

9.  Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy.

Authors:  Patricia A Reis; Clarissa M Comim; Fernanda Hermani; Bruno Silva; Tatiana Barichello; Aline C Portella; Flavia C A Gomes; Ive M Sab; Valber S Frutuoso; Marcus F Oliveira; Patricia T Bozza; Fernando A Bozza; Felipe Dal-Pizzol; Guy A Zimmerman; João Quevedo; Hugo C Castro-Faria-Neto
Journal:  PLoS Pathog       Date:  2010-06-24       Impact factor: 6.823

10.  Phasic-like stimulation of the medial forebrain bundle augments striatal gene expression despite methamphetamine-induced partial dopamine denervation.

Authors:  Christopher D Howard; Elissa D Pastuzyn; Melissa L Barker-Haliski; Paul A Garris; Kristen A Keefe
Journal:  J Neurochem       Date:  2013-04-01       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.